Ligand-independent regulation of ErbB4 receptor phosphorylation by activated ras

Journal of Cellular Biochemistry

Volumn 98, Issue 6, 2006, Pages 1482-1494

  Tal Or, Pazit ^a   Erlich, Shlomit ^a   Porat Shliom, Natalie ^a   Goldshmit, Yona ^a   Ben Baruch, Gilad ^a   Shaharabani, Ezra ^b   Kloog, Yoel ^a   Pinkas Kramarski, Ronit ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b RABIN MEDICAL CENTER   (Israel)

Author keywords

ErbB HER family; ErbB4; HER4; Neuregulin (NRG); Ras; Tyrosine kinase

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 4; ISOENZYME; LIGAND; MITOGEN ACTIVATED PROTEIN KINASE; MUTANT PROTEIN; NEU DIFFERENTIATION FACTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN TYROSINE KINASE; RAF PROTEIN; RAL PROTEIN; RAS PROTEIN; RECEPTOR PROTEIN;

ANIMAL CELL; ARTICLE; AUTOCRINE EFFECT; CELL DIFFERENTIATION; CELL GROWTH; CELL STRAIN; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; HORMONE RELEASE; NERVE FIBER GROWTH; NONHUMAN; ONCOGENE H RAS; ONCOGENE K RAS; ONCOGENE N RAS; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN PHOSPHORYLATION; RAT; RECEPTOR BINDING; RECEPTOR BLOCKING; SIGNAL TRANSDUCTION;

ANIMALS; AUTOCRINE COMMUNICATION; CELL DIFFERENTIATION; GENE EXPRESSION REGULATION; LIGANDS; MODELS, BIOLOGICAL; NERVE TISSUE PROTEINS; NEUREGULIN-1; ONCOGENE PROTEIN P21(RAS); PC12 CELLS; PHOSPHORYLATION; RATS; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES; TRANSFECTION;

EID: 33746471784     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.20815     Document Type: Article

References (45)

1. Bar-Sagi D, Feramisco JR. 1985. Microinjection of the ras oncogene protein into PC12 cells induces morphological differentiation. Cell 42:841-848.
2. Ben-Levy R, Paterson HF, Marshall CJ, Yarden Y. 1994. A single autophosphorylation site confers oncogenicity to the Neu/ErbB-2 receptor and enables coupling to the MAP-kinase pathway. EMBO J 13:3302-3311.
3. Cantley LC, Auger KR, Carpenter C, Duckworth B, Graziani A, Kapeller R, Soltoff S. 1991. Oncogenes and signal transduction. Cell 64:281-302.
4. Carpenter G. 2003. ErbB-4: Mechanism of action and biology. Exp Cell Res 284:66-77.
5. Ciardiello F, McGeady ML, Kim N, Basolo F, Hynes N, Langton BC, Yokozaki H, Saeki T, Elliott JW, Masui H, Mendelson J, Soule H, Russo J, Salomon DS. 1990. Transforming growth factor-alpha expression is enhanced in human mammary epithelial cells transformed by an activated c-Ha-ras proto-oncogene but not by the c-neu proto-oncogene, and overexpression of the transforming growth factor-alpha complementary DNA leads to transformation. Cell Growth Differ 1:407-420.
6. Cox AD, Der CJ. 2003. The dark side of Ras: Regulation of apoptosis. Oncogene 22:8999-9006.
7. Culouscou JM, Carlton GW, Aruffo A. 1995. HER4 receptor activation and phosphorylation of Shc proteins by recombinant heregulin-Fc fusion proteins. J Biol Chem 270:12857-12863.
8. Di Fiore PP, Helin K, Kraus MH, Pierce JH, Artrip J, Segatto O, Bottaro DP. 1992. A single amino acid substitution is sufficient to modify the mitogenic properties of the epidermal growth factor receptor to resemble that of gp185erbB-2. EMBO J 11:3927-3933.
9. Dong Z, Brennan A, Liu N, Yarden Y, Lefkowitz G, Mirsky R, Jessen KR. 1995. Neu differentiation factor is a neuron-glia signal and regulates survival, proliferation, and maturation of rat Schwann cell precursors. Neuron 15:585-596.
10. Erlich S, Goldshmit Y, Lupowitz Z, Pinkas-Kramarski R. 2001. ErbB-4 activation inhibits apoptosis in PC12 cells. Neuroscience 107:353-362.
11. Falls DL, Rosen KM, Corfas G, Lane WS, Fischbach GD. 1993. ARIA, a protein that stimulates acetylcholine receptor synthesis, is a member of the Neu ligand family. Cell 72:801-815.
12. Gana-Weisz M, Haklai R, Marciano D, Egozi Y, Ben-Baruch G, Kloog Y. 1997. The Ras antagonist S-farnesylthiosalicylic acid induces inhibition of MAPK activation. Biochem Biophys Res Commun 239:900-904.
13. Gassmann M, Casagranda F, Orioli D, Simon H, Lai C, Klein R, Lemke G. 1995. Aberrant neural and cardiac development in mice lacking the ErbB4 neuregulin receptor [see comments]. Nature 378:390-394.
14. Goldshmit Y, Erlich S, Pinkas-Kramarski R. 2001. Neuregulin rescue PC12-ErbB4 cells from cell death induced by H2O2: Regulation of reactive oxygen species levels by PI3K. J Biol Chem 276:46379-46385.
15. Goldsmit Y, Erlich S, Pinkas-Kramarski R. 2001. Neuregulin induces sustained reactive oxygen species generation to mediate neuronal differentiation. Cell Mol Neurobiol 21:753-769.
16. Graus-Porta D, Beerli RR, Daly JM, Hynes NE. 1997. ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling. EMBO J 16:1647-1655.
17. Greene LA. 1978. Nerve growth factor prevents the death and stimulates the neuronal differentiation of clonal PC12 pheochromocytoma cells in serum-free medium. J Cell Biol 78:747-755.
18. Greene LA, Tischler AS. 1976. Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc Natl Acad Sci USA 73:2424-2428.
19. He H, Hirokawa Y, Levitzki A, Maruta H. 2000. An anti-Ras cancer potential of PP1, an inhibitor specific for Src family kinases: In vitro and in vivo studies. Cancer J 6:243-248.
20. Higashiyama S, Abraham JA, Miller J, Fiddes JC, Klagsbrun M. 1991. A heparin-binding growth factor secreted by macrophage-like cells that is related to EGF. Science 251:936-939.
21. Hobbs SS, Coffing SL, Le AT, Cameron EM, Williams EE, Andrew M, Blommel EN, Hammer RP, Chang H, Riese DJ II. 2002. Neuregulin isoforms exhibit distinct patterns of ErbB family receptor activation. Oncogene 21:8442-8452.
22. Holmes WE, Sliwkowski MX, Akita RW, Henzel WJ, Lee J, Park JW, Yansura D, Abadi N, Raab H, Lewis GD, Shepard M, Wood WI, Goeddel DV, Vandlen RL. 1992. Identification of heregulin, a specific activator of p185erbB2. Science 256:1205-1210.
23. Joneson T, White MA, Wigler MH, Bar-Sagi D. 1996. Stimulation of membrane ruffling and MAP kinase activation by distinct effectors of RAS. Science 271:810-812.
24. Marchionni MA, Goodearl ADJ, Chen MS, Bermingham-McDonogh O, Kirk C, Hendricks M, Denehy F, Misumi D, Sudhalter J, Kobayashi K, Wroblewski D, Lynch C, Baldassare M, Hues I, Davis JB, Hsuan JJ, Totty NF, Otsu M, McBury RN, Waterfield MD, Stroobant P, Gwynne D. 1993. Glial growth factors are alternatively spliced erbB-2 ligands expressed in the nervous system. Nature 362:312-318.
25. Marshall CJ. 1995. Specificity of receptor tyrosine kinase signaling: Transient versus sustained extracellular signal-regulated kinase activation. Cell 80:179-185.
26. Martinez-Lacaci I, Kannan S, De Santis M, Bianco C, Kim N, Wallace-Jones B, Ebert AD, Wechselberger C, Salomon DS. 2000. RAS transformation causes sustained activation of epidermal growth factor receptor and elevation of mitogen-activated protein kinase in human mammary epithelial cells. Int J Cancer 88:44-52.
27. Normanno N, Ciardiello F. 1997. EGF-related peptides in the pathophysiology of the mammary gland. J Mammary Gland Biol Neoplasia 2:143-151.
28. Normanno N, Selvam MP, Qi CF, Saeki T, Johnson G, Kim N, Ciardiello F, Shoyab M, Plowman G, Brandt R, Todaro G, Salomon DS. 1994. Amphiregulin as an autocrine growth factor for c-Ha-ras- and c-erbB-2-transformed human mammary epithelial cells. Proc Natl Acad Sci USA 91:2790-2794.
29. Peles E, Bacus SS, Koski RA, Lu HS, Wen D, Ogden SG, Ben-Levy R, Yarden Y. 1992. Isolation of the neu/HER-2 stimulatory ligand: A 44 kd glycoprotein that induces differentiation of mammary tumor cells. Cell 69:205-216.
30. Plowman DG, Culouscou J-M, Withney GS, Green JM, Carlton GW, Foy L, Neubauer MG, Shoyab M. 1993a. Ligand-specific activation of HER-4/p180erbB4, a fourth member of the epidermal growth factor receptor family. Proc Natl Acad Sci USA 90:1746-1750.
31. Plowman GD, Green JM, Culouscou J-M, Carlton GW, Rothwell VM, Sharon B. 1993b. Heregulin induces tyrosine phosphorylation of HER4/p180erbB-4. Nature 366:473-475.
32. Puricelli L, Proiettii CJ, Labriola L, Salatino M, Balana ME, Ghiso JA, Lupu R, Pignataro OP, Charreau EH, Bal de Kier Joffe E, Elizalde PV. 2002. Heregulin inhibits proliferation via ERKs and phosphatidyl-inositol 3-kinase activation but regulates urokinase plasminogen activator independently of these pathways in metastatic mammary tumor cells. Int J Cancer 100:642-653.
33. Reuther GW, Der CJ. 2000. The Ras branch of small GTPases: Ras family members don't fall far from the tree. Curr Opin Cell Biol 12:157-165.
34. Riese DJ, Bermingham Y, van Raaij TM, Buckley S, Plowman GD, Stern DF. 1996. Betacellulin activates the epidermal growth factor receptor and erbB-4, and induces cellular response pattern distinct from those stimulated by epidermal growth factor or neuregulin-b. Oncogene 12:345-353.
35. Riese DJ 2nd, Komurasaki T, Plowman GD, Stern DF. 1998. Activation of ErbB4 by the bifunctional epidermal growth factor family hormone epiregulin is regulated by ErbB2. J Biol Chem 273:11288-11294.
36. Roy S, Plowman S, Rotblat B, Prior I, Muncke C, Grainger S, Parton RG, Henis Y, Kloog Y, Hancock J. 2005. Individual palmitoyl residues serve distinct roles in h-ras trafficking, microlocalization, and signaling. Mol Cell Biol 25:6722-6733.
37. Rusanescu G, Gotoh T, Tian X, Feig LA. 2001. Regulation of Ras signaling specificity by protein kinase C. Mol Cell Biol 21:2650-2658.
38. Shelly M, Pinkas-Kramarski R, Guarino BC, Waterman H, Wang LM, Lyass L, Alimandi M, Kuo A, Bacus SS, Pierce JH, Andrews GC, Yarden Y. 1998. Epiregulin is a potent pan-ErbB ligand that preferentially activates heterodimeric receptor complexes. J Biol Chem 273:10496-10505.
39. Sweeney C, Carraway KL, 3rd. 2000. Ligand discrimination by ErbB receptors: Differential signaling through differential phosphorylation site usage. Oncogene 19:5568-5573.
40. Thornton C, Yaka R, Dinh S, Ron D. 2003. H-Ras modulates N-methyl-D-aspartate receptor function via inhibition of Src tyrosine kinase activity. J Biol Chem 278:23823-23829.
41. Ullrich A, Schlessinger J. 1990. Signal transduction by receptors with tyrosine kinase activity. Cell 61:203-212.
42. Vaskovsky A, Lupowitz Z, Erlich S, Pinkas-Kramarski R. 2000. ErbB-4 activation promotes neurite outgrowth in PC12 cells. J Neurochem 74:979-987.
43. Wen D, Peles E, Cupples R, Suggs SV, Bacus SS, Luo Y, Trail G, Hu S, Silbiger SM, Ben-Levy R, Luo Y, Yarden Y. 1992. Neu differentiation factor: A transmembrane glycoprotein containing an EGF domain and an immunoglobulin homology unit. Cell 69:559-572.
44. Yarden Y, Kelman Z. 1991. Transmembrane signaling receptors for cytokines and growth factors. Cur Op Struc Biol 1:582-589.
45. Yarden Y, Peles E. 1991. Biochemical analysis of the ligand for the neu oncogenic receptor. Biochemistry 30:3543-3550.